Mutational and functional analysis of HPV-16 URR derived from Korean cervical neoplasia

Gynecologic Oncology

Volumn 74, Issue 1, 1999, Pages 23-29

  Park, Jong Sup ^a   Hwang, Eun Seong ^b   Lee, Chan Jae ^b   Kim, Chan Joo ^a   Rha, Jong Gu ^a   Kim, Seung Jo ^a   Namkoong, Sung Eun ^a   Um, Soo Jong ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b University of Seoul   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SOUTH KOREA; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR; VIRUS CARCINOGENESIS; VIRUS GENE; WART VIRUS;

EID: 0005819410     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5399     Document Type: Article

References (32)

1. Zur Hausen H. Human papillomavirus in anogenital cancer as a model to understanding the role of viruses in human cancer. Cancer Res. 49:1989;4677-4681.
2. Matsukura T, Koi S, Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology. 172:1989;63-72.
3. Cullen A P, Reid R, Campion M, Lorincz A T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasia. J Virol. 65:1991;606-612.
4. Park J S, Hwang E S, Park S N, Ahn H K, Um S J, Kim C J, Kim S J, Namkoong S E. Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol. 65:1997;121-126.
5. Zur Hausen H. Human papillomavirus in the pathogenesis of anogenital cancer. Virology. 184:1991;9-13.
6. Dyson M, Howley P M, Munger K, Harlow E. The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:1989;934-937.
7. Werness B A, Levine A J, Howley P M. Association of human papillomavirus type 16 and 18 proteins with p53. Science. 248:1990;76-79.
8. DiMaio D. Transforming activity of bovine and human papillomaviruses in cultured cells. Adv Cancer Res. 56:1991;133-159.
9. Munger K, Phels W C, Bubb V, Howley P M, Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 63:1991;4417-4421.
10. Smotkin D, Prokoph H, Wettstein F O. Oncogenic and non-oncogenic human paillomaviruses generate the E6 and E7 mRNA by different mechanism. J Virol. 63:1989;1441-1447.
11. McBride A A, Romanczuk H, Howley P M. The papillomavirus E2 regulatory gene proteins. J Biol Chem. 266:1991;18411-18414.
12. Kyo S, Inoue M, Nishio Y, Nakanishi K, Akira S, Inoue H, Yutsudo M, Tanizawa O, Hakura A. NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region. J Virol. 67:1993;1058-1066.
13. Hoppe-Seyler F, Butz K, zur Hausen H. Repression of human papillomavirus type-18 enhancer by the cellular transcription factor Oct-1. J Virol. 65:1991;5613-5618.
14. May M, Dong X P, Beyer-Finkler E, Stubenrauch F, Fuchs P G, Pfister H. The E6/E7 promoter of extrachromosomal HPV-16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 13:1994;1460-1466.
15. Dong X P, Stubenrauch F, Beyer-Finkler E, Pfiester H. Prevalence of deletions of YY1 binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer. 58:1994;803-808.
16. O'Connor M J, Tan S H, Tan C H, Bernard H U. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol. 70:1996;6529-6539.
17. Chen Z, Storthz K A, Shillitoe E J. Mutations in the long control region of human papillomavirus DNA in oral cancer cells, and their functional consequences. Cancer Res. 57:1997;1614-1619.
18. Sanger F, Nicklen S, Coulson A R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 74:1977;5463-5467.
19. Seedorf K, Kraemmer G, Durst M, Suhai S, Roewekamp W P. Human papillomavirus type 16 sequence. Virology. 145:1985;181-185.
20. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
21. McBride A A, Myers G. The E2 proteins. Myers G, Bernard H-U, Baker C, Halpern A, Delius H, Icenogle J. Human Papillomavuruses 1997. 1997;III 54-III 73 Los Alamos Laboratory.
22. Kovelman R, Bilter G E, Glezer E, Tsou A Y, Barbosa M S. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses. J Virol. 70:1996;7549-7560.
23. Dostatni N, Lambert P F, Sousa R, Ham J, Howley P M, Yaniv M. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev. 5:1991;1657-1671.
24. Tan S H, Leong L E, Walker P A, Bernard H U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol. 68:1994;6411-6420.
25. Lambert P F. Papillomavirus DNA replication. J Virol. 65:1991;3417-3420.
26. O'Conner M, Chan S-Y, Bernard H-U. Transcriptional Factor Binding Sites in the Long Control Region of Genital HPVs. Myers G, Bernard H-U, Baker C, Halpern A, Delius H, Icenogle J. Human Papillomaviruses 1995. 1995;III 21-III 40 Los Alamos Laboratory.
27. Bauknecht T, Jundt F, Herr I, Oehler T, Delius H, Shi Y, Angel P, zur Hausen H. , A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter. J Virol. 69:1995;1-12.
28. Bauknecht T, Angel P, Royer H D, zur Hausen H. Identification of a negative regulatory domain in the human papillomavirus type-18 promoter: interaction with the transcription repressor YY1. EMBO J. 11:1992;4607-4617.
29. Bartsch D, Boye B, Baust C, zur Hausen H, Schwarz E. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor β gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J. 11:1992;2283-2291.
30. Chan S Y, Ho L, Ong C K, Chow V, Drescher B, Durst M, Meulen J ter, Villa L, Luande F, Mgaya H N, Bernard H-U. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol. 66:1992;2057-2066.
31. Ho L, Chan S-Y, Burk R D, Das B C, Fujinanga K, Icenogle J P, Kahn T, Kiviat N, Lancaster W, Mavromara-Naraz P, Labropoulou V, Mitrani-Rosenbaum S, Norrild M, Pillai M R, Stoerker J, Sjrjaenen K, Sjrjaenen S, Tay S K, Villa L L, Wheeler C M, Williamson A L, Bernard H-U. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human ethnic groups. J Virol. 67:1993;6413-6423.
32. Yamada T, Wheeler C M, Halpern A L, Sterwart A CM, Hildersheim A, Jenison S A. Human papillomavirus type 16 variants lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 69:1995;7743-7753.